Vistagen therapeutics reports qtrly loss per share of $0.07

Vistagen therapeutics reports fiscal 2021 first quarter financial results and highlights cns pipeline and business progress.vistagen therapeutics inc - qtrly loss per share $0.07.
VTGN Ratings Summary
VTGN Quant Ranking